Introducing OdysseaBio
Your partner in navigating the path of innovative therapies.
We specialize in stakeholder communication strategies for lean teams in biotech, pharma, and patient advocacy. Whether you're aligning internal teams, shaping external narratives, or preparing for critical milestones, we help you get there faster—with less back-and-forth and more strategic momentum.
The Challenge and Our Approach
Redefining Medical Communications for
Life Science Trailblazers
The name OdysseaBio reflects the journey of drug development—long, complex, and full of unexpected turns. But too often, groundbreaking science is held back by traditional communications models that can't keep pace with fast-moving, lean teams.
We’re here to change that.
At OdysseaBio, we partner with emerging biotech, pharma, and patient advocacy teams to transform complex science into clear, compelling narratives that drive action.
Our approach blends strategic storytelling with scientific depth—so your message lands with the audiences who matter most: investors, clinicians, and patient communities.
Every innovation is different. That’s why our scalable toolkits and custom frameworks are designed to help you stay focused, move faster, and communicate with clarity—without the bottlenecks of traditional med comms services.
What We Deliver and How We Work
Clarity, Strategy, and Tools Built for Impact
We develop high-impact communication strategies delivered as curated, ready-to-use toolkits—built specifically for lean teams navigating critical milestones.
Whether you're raising funds, launching a therapy, or preparing for a pivotal engagement, our toolkits help you clarify your message, align stakeholders, and communicate your science with precision and purpose.
When depth and nuance are essential, we offer tailored strategic support to help you navigate high-stakes communication moments.
Starting with structured inputs and focused research, we move quickly to high-impact working sessions and targeted feedback—every step designed to meet you where you are and move you forward, faster.
The OdysseaBio Co-Founders
We bring 40+ years of combined experience—from lab benches to the strategic frontline—translating complex science into narratives that connect and resonate.
As two scientists who’ve embraced the power of communication, we’re passionate about helping lean teams find their voice and make a real impact.
Deborah Maret, PhD
Glioblastoma research background with strong insight into preclinical-to-clinical development
Medical affairs and commercial expertise, turning complex data, including RWD/RWE, into actionable insights for HCPs and patient groups
Developed preclinical study reports and strategic narratives for biotech startups
Led strategic education initiatives, crafting evidence-based materials, manuscripts, and congress presentations for diverse clinical audiences
Georghia Michael, PhD
Research background in preclinical models of arrhythmia and heart failure
Extensive market access and reimbursement experience delivering value stories, global value dossiers, and HTA submissions for rare disease therapies
Turned expert insights into strategic messaging from 75+ advisory boards attended
Covered 10+ international conferences and created content aligned with clinical and commercial goals